NFATC1 and carcinoma: Dynamic imbalance of DNMT is linked to atherosclerosis through CD137/NFATc1 signaling [48], and is implicated in many kinds of carcinoma, including breast cancer [49], liver cancer [28], and thyroid cancer [50].